Vimarsana
Biggest News Aggregation in the World

Quentinm Anstee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quentinm Anstee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quentinm Anstee Today - Breaking & Trending Today

INVENTIVA: Inventiva announces five scientific presentations at the EASL International Liver Congress 2023 - Vimarsana News

INVENTIVA: Inventiva announces five scientific presentations at the EASL International Liver Congress 2023

Five poster presentations showing: the correlation between the improvement of hepatic steatosis and a robust increase in adiponectin levels, improvement in lipid profile and glycemic control in patients

Inventiva announces five scientific presentations at the EASL International Liver Congress 2023 - Vimarsana News

Inventiva announces five scientific presentations at the EASL International Liver Congress 2023

07.06.2023 - Five poster presentations showing : the correlation between the improvement of hepatic steatosis and a robust increase in adiponectin levels, improvement in lipid profile and glycemic control in patients with non-cirrhotic NASH treated with ...

Stock Market | FinancialContent Business Page - Vimarsana News

Stock Market | FinancialContent Business Page

FinancialContent fully hosted finance channel

Intercept Announces New Data to be Presented in PBC, Liver Fibrosis due to NASH and Pipeline at AASLD The Liver Meeting® 2022 - Vimarsana News

Intercept Announces New Data to be Presented in PBC, Liver Fibrosis due to NASH and Pipeline at AASLD The Liver Meeting® 2022

Data from Phase 3 REGENERATE study supporting positive benefit-risk profile of obeticholic acid in liver fibrosis due to NASH to be featured in late-breaker podium presentation Analysis... | October 31, 2022

HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials - Vimarsana News

HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials

This is a first-of-its-kind international study initiated in 2019 by HistoIndex to examine artificial intelligence (AI)-based approaches that may provide a...